Indian court denies Merck interim relief in Glenmark diabetes patent case 5 April 2013 / By Tim / Featured on app, Regulation and Government / 0 comments
Big pharma suffers as patents expire… but great opportunities for generics companies 26 October 2012 / By Carly / Featured on app / 0 comments
Top 5 books everyone in the biopharma industry must read 31 July 2012 / By justine / Regulation and Government / 0 comments
What will happen to pharma in India, as the country looks to generics? 26 July 2012 / By justine / Regulation and Government / 0 comments
How 2012 is stacking up for the #Pharmas 21 May 2012 / By natalies / Supply Chain & Manufacturing / 0 comments
Watson to become world’s 3rd largest #Generics Drug Maker with the #acquisition of Actavis 26 April 2012 / By natalies / Partnering & Investment / 0 comments
Novartis charging in the race for generics 5 April 2012 / By natalies / Drug Discovery, Manufacturing / 0 comments
Medicines to lose some of their ‘pricey’ tags 2 April 2012 / By natalies / Manufacturing / 0 comments
Generics key to improving Australian economy 7 March 2012 / By scottmoore / Manufacturing / 0 comments
Generic Growth Strategies – Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues 5 March 2012 / By alice / Manufacturing / 0 comments
